PALO ALTO, Calif., March 11, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has ...
FDA greenlights Shield blood test for colorectal cancer screening. NEW YORK, July 29: The FDA has granted approval for Shield, a new blood test developed by Guardant Health, aimed at early detection ...
July 29 (Reuters) - Guardant Health (GH.O), opens new tab said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback